|
Laryngeal Muscles
|
A04.329.604 |
|
|
Carbamazepine
|
D002220 |
[A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
] |
|
Carbamyl Phosphate
|
D002221 |
[The monoanhydride of carbamic acid with PHOSPHORIC ACID. It is an important intermediate metabolite and is synthesized enzymatically by CARBAMYL-PHOSPHATE SYNTHASE (AMMONIA) and CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING).
] |
|
Receptor, ErbB-4
|
D23.101.140.760 |
|
|
Carbanilides
|
D002224 |
[Compounds consisting of two phenyl groups joined by a urea. Derivatives may be used as ANTIPARASITIC AGENTS.
] |
|
Carbazilquinone
|
D002225 |
[An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
] |
|
Carbamoyl-Phosphate Synthase (Ammonia)
|
D002222 |
[An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.
] |
|
Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)
|
D002223 |
[An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.
] |
|
Ureaplasma Infections
|
D016869 |
[Infections with bacteria of the genus UREAPLASMA.
] |
|
Immunocompromised Host
|
D016867 |
[A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
] |
|
Xenophobia
|
D065806 |
[Intense or irrational dislike or fear of anything that is strange or foreign, particularly of people who are strangers or foreigners. It is an attitudinal orientation of hostility against non-natives in a given population that includes attitudes, prejudices and behavior that reject, exclude or vilify persons, based on the perception that they are outsiders or foreigners to the community, society or national identity.
] |
|
Serratia Infections
|
D016868 |
[Infections with bacteria of the genus SERRATIA.
] |
|
Prepulse Inhibition
|
D065808 |
[A neurophysiological phenomenon in which the response to a startling stimulus (pulse) is decreased when a weaker prestimulus (prepulse) precedes it closely in time. It is used as an operational measure of sensorimotor gating.
] |
|
Respiratory Sinus Arrhythmia
|
D065809 |
[A naturally occurring variation in heart rate that occurs during a BREATHING cycle, where the time between heartbeats is shortened during inspiration and prolonged during expiration. It is not the same as SINUS ARRHYTHMIA, the disorder.
] |
|
Corpus Luteum
|
A05.360.319.114.630.278 |
|
|
SMN Complex Proteins
|
D12.776.580.922 |
|
|
Cyclooxygenase Inhibitors
|
D016861 |
[Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
] |
|
Tuberculoma, Intracranial
|
D016862 |
[A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with SEIZURES, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as OPPORTUNISTIC INFECTIONS, but also occur in immunocompetent individuals.
] |
|
Receptors, Cholecystokinin
|
D12.776.543.750.695.170 |
|
|
CD4 Immunoadhesins
|
D016860 |
[Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin.
] |
